Previous Article | Next Article ![]()
J. Bacteriol., 08 1995, 4327-4332, Vol 177, No. 15
P Zhong, SD Pratt, RP Edalji, KA Walter, TF Holzman, AG Shivakumar and L Katz
ErmC' is a methyltransferase that confers resistance to the macrolide-
lincosamide-streptogramin B group of antibiotics by catalyzing the
methylation of 23S rRNA at a specific adenine residue (A-2085 in Bacillus
subtilis; A-2058 in Escherichia coli). The gene for ErmC' was cloned and
expressed to a high level in E. coli, and the protein was purified to
virtual homogeneity. Studies of substrate requirements of ErmC' have shown
that a 262-nucleotide RNA fragment within domain V of B. subtilis 23S rRNA
can be utilized efficiently as a substrate for methylation at A-2085.
Kinetic studies of the monomethylation reaction showed that the apparent Km
of this 262-nucleotide RNA oligonucleotide was 26-fold greater than the
value determined for full-size and domain V 23S rRNA. In addition, the Vmax
for this fragment also rose sevenfold. A model of RNA-ErmC' interaction
involving multiple binding sites is proposed from the kinetic data
presented.
Copyright © 1995, American Society for Microbiology
Substrate requirements for ErmC' methyltransferase activity
Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064, USA.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |